These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 16825485)
1. Molecular determinants of pyrantel selectivity in nicotinic receptors. Bartos M; Rayes D; Bouzat C Mol Pharmacol; 2006 Oct; 70(4):1307-18. PubMed ID: 16825485 [TBL] [Abstract][Full Text] [Related]
2. Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle. Rayes D; Flamini M; Hernando G; Bouzat C Mol Pharmacol; 2007 May; 71(5):1407-15. PubMed ID: 17314321 [TBL] [Abstract][Full Text] [Related]
3. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors. Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482 [TBL] [Abstract][Full Text] [Related]
4. Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris. Martin RJ; Clark CL; Trailovic SM; Robertson AP Int J Parasitol; 2004 Aug; 34(9):1083-90. PubMed ID: 15313135 [TBL] [Abstract][Full Text] [Related]
5. Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for {alpha}7 nicotinic receptors. Bartos M; Price KL; Lummis SC; Bouzat C J Biol Chem; 2009 Aug; 284(32):21478-87. PubMed ID: 19506073 [TBL] [Abstract][Full Text] [Related]
6. Determinants of channel gating located in the N-terminal extracellular domain of nicotinic alpha7 receptor. Anand R; Nelson ME; Gerzanich V; Wells GB; Lindstrom J J Pharmacol Exp Ther; 1998 Nov; 287(2):469-79. PubMed ID: 9808669 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance. Kopp SR; Coleman GT; Traub RJ; McCarthy JS; Kotze AC Int J Parasitol; 2009 Mar; 39(4):435-41. PubMed ID: 18823982 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the differential sensitivity of nematode and mammalian muscle to the anthelmintic agent levamisole. Rayes D; De Rosa MJ; Bartos M; Bouzat C J Biol Chem; 2004 Aug; 279(35):36372-81. PubMed ID: 15201284 [TBL] [Abstract][Full Text] [Related]
10. Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle. Atchison WD; Geary TG; Manning B; VandeWaa EA; Thompson DP Toxicol Appl Pharmacol; 1992 Jan; 112(1):133-43. PubMed ID: 1310165 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic contributions of residues in the M1 transmembrane domain of the nicotinic receptor to channel gating. Spitzmaul G; Corradi J; Bouzat C Mol Membr Biol; 2004; 21(1):39-50. PubMed ID: 14668137 [TBL] [Abstract][Full Text] [Related]
12. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57. Martin RJ; Robertson AP Parasitology; 2007; 134(Pt 8):1093-104. PubMed ID: 17608969 [TBL] [Abstract][Full Text] [Related]
13. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans. Ruiz-Lancheros E; Viau C; Walter TN; Francis A; Geary TG Int J Parasitol; 2011 Mar; 41(3-4):455-61. PubMed ID: 21195075 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a mutated chicken alpha7 nicotinic acetylcholine receptor subunit with a leucine residue inserted in transmembrane domain 2. Buckingham SD; Adcock C; Sansom MS; Sattelle DB; Baylis HA Br J Pharmacol; 1998 Jun; 124(4):747-55. PubMed ID: 9690867 [TBL] [Abstract][Full Text] [Related]
16. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species. Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008 [TBL] [Abstract][Full Text] [Related]
17. The anthelmintic pyrantel acts as a low efficacious agonist and an open-channel blocker of mammalian acetylcholine receptors. Rayes D; De Rosa MJ; Spitzmaul G; Bouzat C Neuropharmacology; 2001 Aug; 41(2):238-45. PubMed ID: 11489460 [TBL] [Abstract][Full Text] [Related]
18. Role of the outer beta-sheet in divalent cation modulation of alpha7 nicotinic receptors. McLaughlin JT; Fu J; Sproul AD; Rosenberg RL Mol Pharmacol; 2006 Jul; 70(1):16-22. PubMed ID: 16533908 [TBL] [Abstract][Full Text] [Related]
19. Effects of mutations of a glutamine residue in loop D of the alpha7 nicotinic acetylcholine receptor on agonist profiles for neonicotinoid insecticides and related ligands. Shimomura M; Okuda H; Matsuda K; Komai K; Akamatsu M; Sattelle DB Br J Pharmacol; 2002 Sep; 137(2):162-9. PubMed ID: 12208772 [TBL] [Abstract][Full Text] [Related]
20. Mutations of a conserved lysine residue in the N-terminal domain of alpha7 nicotinic receptors affect gating and binding of nicotinic agonists. Criado M; Mulet J; Bernal JA; Gerber S; Sala S; Sala F Mol Pharmacol; 2005 Dec; 68(6):1669-77. PubMed ID: 16129734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]